alexa Abstract | Evaluation of Novel Compound Benzoylphenyl-Indole-Carboxamide Effect on Hyperlipidemic and Hyperglycemic Rat

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


Hyperlipidemia is one of the most risk factors involved in the development of cardiovascular disease. As a consequence of hyperlipidemia treatment, a high demand for new oral antihyperlipidemic drugs is required. The present study was designed to investigate the potential effect of a novel compound N-[4-benzoylphenyl]-1H-indole- 2-carboxamide on diet-induced hyperlipidemic (prepared by mixing cholesterol 0.5%, 0.25 % cholic acid, 20% fat and 2% corn oil with standard powdered animal food for two months) , triton-induced hyperlipidemic (by intraperitoneal injection of Triton WR-1339 250 mg/kg body weight) and alloxan-induced hyperglycemic rats (150 mg/kg body weight injected intraperitoneally). Lipid profiles [Total cholesterol (TC), Triglyceride (TG), Low Density Lipoprotein (LDL) and High Density Lipoprotein (HDL)] in all groups showed significant (p < 0.05) changes (±) before treatment. After 24 hrs of treatment with N-[4-benzoylphenyl]-1H-indole-2-carboxamide (15 mg/kg body weight), significant decrease (p <0.05) in serum cholesterol level 60%, , triglyceride 33-45%, LDL 32% and increase HDL 58% levels. Nevertheless, antihyperlipidemic fenofibrate - used as standard reference - showed parallel results to the novel compound. In addition, body weight of diet-induced hyperlipidemic rats decreased about 20%. On the other hand, the novel compound showed no significant effect on glucose level of hyperglycemic rats. In conclusion, the results indicate that N-[4-benzoylphenyl]-1H-indole-2-carboxamide possesses significant antihyperlipidemic activity and may conserve a promising potential effect in the treatment of hyperlipidemia correlated to heart diseases.

To read the full article Peer-reviewed Article PDF image

Author(s): Mahmoud AlShawabkeh Abdulrahim Al Jamal and Omaymah Ghaleb AlJamal


Hyperlipidemia, Hyperglycemia, [4-Benzoylphenyl]-1H-Indole-2-Carboxamide, Lipid Profiles, Triton, Alloxan, Hyperlipidemic, Hyperglycemic

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version